Examining Efficacy of In Vivo Treatments & Sharing Pre-Clinical Data
Time: 1:15 pm
day: Conference Day One
Details:
- Addressing clinical CAR-T indications, efficacy signals, the need for lymphodepletion, effective doses, toxicities, and correlatives (integrations per cell, durability, exhaustion etc.)
- Evaluating the performance of in vivo generated CAR-T cells in well-known pre-clinical models to allow us to predict likely clinical superiority
